000 | 01307 a2200361 4500 | ||
---|---|---|---|
005 | 20250513113405.0 | ||
264 | 0 | _c19970403 | |
008 | 199704s 0 0 eng d | ||
022 | _a0093-7754 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJohnson, D H | |
245 | 0 | 0 |
_aPaclitaxel, 5-fluorouracil, and folinic acid in metastatic breast cancer: BRE-26, a phase II trial. _h[electronic resource] |
260 |
_bSeminars in oncology _cFeb 1997 |
||
300 |
_aS22-5 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aFatigue _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMucous Membrane _xdrug effects |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 |
_aNervous System Diseases _xchemically induced |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
700 | 1 | _aPaul, D | |
700 | 1 | _aHande, K R | |
773 | 0 |
_tSeminars in oncology _gvol. 24 _gno. 1 Suppl 3 _gp. S22-5 |
|
999 |
_c9058607 _d9058607 |